Novo Nordisk Scores First FDA Approval for an Oral GLP-1 Drug for Obesity
On December 22, 2025, the U.S. Food and Drug Administration officially approved the once-daily oral version of Wegovy (semaglutide 25 mg) as the **first…
On December 22, 2025, the U.S. Food and Drug Administration officially approved the once-daily oral version of Wegovy (semaglutide 25 mg) as the **first…
New to Hive?
Signup